BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 19691510)

  • 1. Splenectomy as an adjunctive treatment for dogs with immune-mediated hemolytic anemia: ten cases (2003-2006).
    Horgan JE; Roberts BK; Schermerhorn T
    J Vet Emerg Crit Care (San Antonio); 2009 Jun; 19(3):254-61. PubMed ID: 19691510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Splenectomy in dogs with immune-mediated hemolytic anemia].
    Slappendel RJ
    Tijdschr Diergeneeskd; 2004 Jan; 129(1):20-1. PubMed ID: 14737813
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of thromboelastography in dogs with immune-mediated hemolytic anemia: 39 cases (2000-2008).
    Sinnott VB; Otto CM
    J Vet Emerg Crit Care (San Antonio); 2009 Oct; 19(5):484-8. PubMed ID: 19821891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Splenectomy in the management of primary immune-mediated hemolytic anemia and primary immune-mediated thrombocytopenia in dogs.
    Bestwick JP; Skelly BJ; Swann JW; Glanemann B; Bexfield N; Gkoka Z; Walker DJ; Silvestrini P; Adamantos S; Seth M; Warland J
    J Vet Intern Med; 2022 Jul; 36(4):1267-1280. PubMed ID: 35801263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune-mediated hemolytic anemia and severe thrombocytopenia in dogs: 12 cases (2001-2008).
    Orcutt ES; Lee JA; Bianco D
    J Vet Emerg Crit Care (San Antonio); 2010 Jun; 20(3):338-45. PubMed ID: 20636987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous administration of human immune globulin in dogs with immune-mediated hemolytic anemia.
    Scott-Moncrieff JC; Reagan WJ; Snyder PW; Glickman LT
    J Am Vet Med Assoc; 1997 Jun; 210(11):1623-7. PubMed ID: 9170090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Canine immune-mediated hemolytic anemia: treatment and prognosis.
    Balch A; Mackin A
    Compend Contin Educ Vet; 2007 Apr; 29(4):230-8; quiz 239. PubMed ID: 17726852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of human immunoglobulin in addition to glucocorticoids for the initial treatment of dogs with immune-mediated hemolytic anemia.
    Whelan MF; O'Toole TE; Chan DL; Rozanski EA; DeLaforcade AM; Crawford SL; Cotter SM
    J Vet Emerg Crit Care (San Antonio); 2009 Apr; 19(2):158-64. PubMed ID: 19691566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune-mediated haemolytic anaemia in 110 dogs in Victoria, Australia.
    McAlees TJ
    Aust Vet J; 2010 Jan; 88(1-2):25-8. PubMed ID: 20148823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Idiopathic immune-mediated hemolytic anemia in dogs: 42 cases (1986-1990).
    Klag AR; Giger U; Shofer FS
    J Am Vet Med Assoc; 1993 Mar; 202(5):783-8. PubMed ID: 8454517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of blood lactate concentration with outcome in dogs with idiopathic immune-mediated hemolytic anemia: 173 cases (2003-2006).
    Holahan ML; Brown AJ; Drobatz KJ
    J Vet Emerg Crit Care (San Antonio); 2010 Aug; 20(4):413-20. PubMed ID: 20731807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epirubicin in the adjuvant treatment of splenic hemangiosarcoma in dogs: 59 cases (1997-2004).
    Kim SE; Liptak JM; Gall TT; Monteith GJ; Woods JP
    J Am Vet Med Assoc; 2007 Nov; 231(10):1550-7. PubMed ID: 18021000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune-mediated hemolytic anemia: 70 cases (1988-1996).
    Reimer ME; Troy GC; Warnick LD
    J Am Anim Hosp Assoc; 1999; 35(5):384-91. PubMed ID: 10493413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfusion practices for treatment of dogs undergoing splenectomy for splenic masses: 542 cases (2001-2012).
    Lynch AM; O'Toole TE; Hamilton J
    J Am Vet Med Assoc; 2015 Sep; 247(6):636-42. PubMed ID: 26331422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of different prognostic markers in dogs with primary immune-mediated hemolytic anemia].
    Griebsch C; Arndt G; Kohn B
    Berl Munch Tierarztl Wochenschr; 2010; 123(3-4):160-8. PubMed ID: 20329649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Splenectomy as adjunctive therapy for immune-mediated thrombocytopenia and hemolytic anemia in the dog.
    Feldman BF; Handagama P; Lubberink AA
    J Am Vet Med Assoc; 1985 Sep; 187(6):617-9. PubMed ID: 4086369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Canine immune-mediated hemolytic anemia: pathophysiology, clinical signs, and diagnosis.
    Balch A; Mackin A
    Compend Contin Educ Vet; 2007 Apr; 29(4):217-25. PubMed ID: 17726851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of idiopathic immune-mediated hemolytic anemia with mycophenolate mofetil in five dogs.
    West LD; Hart JR
    J Vet Emerg Crit Care (San Antonio); 2014; 24(2):226-31. PubMed ID: 24251650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Idiopathic immune-mediated hemolytic anemia: treatment outcome and prognostic factors in 149 dogs.
    Piek CJ; Junius G; Dekker A; Schrauwen E; Slappendel RJ; Teske E
    J Vet Intern Med; 2008; 22(2):366-73. PubMed ID: 18346140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary thromboembolism associated with immune-mediated hemolytic anemia in dogs: ten cases (1982-1987).
    Klein MK; Dow SW; Rosychuk RA
    J Am Vet Med Assoc; 1989 Jul; 195(2):246-50. PubMed ID: 2768046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.